共 59 条
- [1] Walsh TJ(2008)Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 327-360
- [2] Anaissie EJ(2004)Adverse reactions to voriconazole Clin Infect Dis 39 1241-1244
- [3] Denning DW(2015)Phototoxicity, pseudoporphyria and photo-onycholysis due to voriconazole in a pediatric patient with leukemia and invasive aspergillosis J pediatric Infect Dis Soc 4 e22-e24
- [4] Boyd AE(2004)Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect Clin Infect Dis 39 e49-e52
- [5] Modi S(2011)Voriconazole-induced QT interval prolongation and torsades de pointes Pediatr Int 53 761-763
- [6] Howard SJ(2007)Torsades de pointes associated with voriconazole use Transpl Infect Dis 9 33-36
- [7] Moore CB(2012)QTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy Eur Rev Med Pharmacol Sci 16 100-102
- [8] Keevil BG(2014)Voriconazole associated torsades de pointes in two adult patients with haematological malignancies Med Mycol Case Rep 13 23-25
- [9] Denning DW(2013)Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients Antimicrob Agents Chemother 57 1121-1127
- [10] Willis ZI(2013)Drug-induced arrhythmia: pharmacogenomic prescribing? Eur Heart J 34 89-95